Monograph

J01CR05 - Piperacillin and Beta-Lactamase Inhibitor

Propably not porphyrinogenic

Rationale

Piperacillin: Not metabolized.Two references consider it safe. Tazobactam: Mainly excreted in unchanged form.

Chemical description

Piperacillin: Broadspectrum penicillin used parenterally (4 g x 3) in septicemia where Pseudomonas infection is verified or suspected. Excreted in bile and by the kidneys in unchanged form. No data pointing to CYP interaction. Tazobact: Betalactamase inhibitor (up to 500 mg / 24 h) mainly excreted via the kidneys in unchanged form. Piperacillin: South African list: use. EPI-list: safe. Tazobactam: South African list: no data/avoid.

IPNet drug reports

Uneventful use reported in 2 patients with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes J01C / J01CR or go back.

Tradenames

This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Show more details and information about the listed tradenames